Chronic Inhalation Exposure to Antimony Trioxide Exacerbates the MAPK Signaling in Alveolar Bronchiolar Carcinomas in B6C3F1/N Mice
Toxicologic Pathology · 2023
DOI: 10.1177/01926233231157322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, 2023. Verfasst von Thai-Vu T Ton und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Bronchiolo-Alveolar, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, DNTP/NIEHS intramural program, National Institute of Environmental Health Sciences.
Abstract (Originalsprache)
Antimony trioxide (AT) is used as a flame retardant in fabrics and plastics. Occupational exposure in miners and smelters is mainly through inhalation and dermal contact. Chronic inhalation exposure to AT particulates in B6C3F1/N mice and Wistar Han rats resulted in increased incidences and tumor multiplicities of alveolar/bronchiolar carcinomas (ABCs). In this study, we demonstrated Kras (43%) and Egfr (46%) hotspot mutations in mouse lung tumors (n = 80) and only Egfr (50%) mutations in rat lung tumors (n = 26). Interestingly, there were no differences in the incidences of these mutations in ABCs from rats and mice at exposure concentrations that did and did not exceed the pulmonary overload threshold. There was increased expression of p44/42 mitogen-activated protein kinase (MAPK) (Erk1/2) protein in ABCs harboring mutations in Kras and/or Egfr , confirming the activation of MAPK signaling. Transcriptomic analysis indicated significant alterations in MAPK signaling such as ephrin receptor signaling and signaling by Rho-family GTPases in AT-exposed ABCs. In addition, there was significant overlap between transcriptomic data from mouse ABCs due to AT exposure and human pulmonary adenocarcinoma data. Collectively, these data suggest chronic AT exposure exacerbates MAPK signaling in ABCs and, thus, may be translationally relevant to human lung cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
- Pfizer Inc., Cambridge, Massachusetts, USA.
- Merck & Co., Inc., Rahway, New Jersey, USA.
ORCID-Profile: Ramesh C Kovi, Kyathanahalli S Janardhan, Arun R Pandiri
Förderung
- Intramural NIH HHS
- DNTP/NIEHS intramural program
- National Institute of Environmental Health Sciences
Zitieren
APA
Ton, T. T., Hong, H. L., Kovi, R. C., Shockley, K. R., Peddada, S. D., Gerrish, K. E., Janardhan, K. S., Flake, G., Stout, M. D., Sills, R. C., & Pandiri, A. R. (2023). Chronic Inhalation Exposure to Antimony Trioxide Exacerbates the MAPK Signaling in Alveolar Bronchiolar Carcinomas in B6C3F1/N Mice. Toxicologic Pathology. https://doi.org/10.1177/01926233231157322
Vancouver
Ton TT, Hong HL, Kovi RC, Shockley KR, Peddada SD, Gerrish KE, et al. Chronic Inhalation Exposure to Antimony Trioxide Exacerbates the MAPK Signaling in Alveolar Bronchiolar Carcinomas in B6C3F1/N Mice. Toxicologic Pathology. 2023. doi:10.1177/01926233231157322
BibTeX
@article{Ton2023,
author = {Ton, Thai-Vu T and Hong, Hue-Hua L and Kovi, Ramesh C and Shockley, Keith R and Peddada, Shyamal D and Gerrish, Kevin E and Janardhan, Kyathanahalli S and Flake, Gordon and Stout, Mathew D and Sills, Robert C and Pandiri, Arun R},
title = {Chronic Inhalation Exposure to Antimony Trioxide Exacerbates the MAPK Signaling in Alveolar Bronchiolar Carcinomas in B6C3F1/N Mice},
journal = {Toxicologic Pathology},
year = {2023},
doi = {10.1177/01926233231157322}
}
EUVIMED